Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
SZSE:300760.SZ
256.8 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 34,565.824 | 30,365.644 | 25,269.581 | 21,025.846 | 16,555.991 | 13,753.357 | 11,173.795 | 9,031.723 | 8,013.11 | 7,835.718 |
| Kosten van de omzet
| 12,566.874 | 10,885.289 | 8,842.715 | 7,366.094 | 5,755.057 | 4,597.398 | 3,684.012 | 3,195.252 | 3,027.702 | 2,865.658 |
| Brutowinst
| 21,998.95 | 19,480.354 | 16,426.866 | 13,659.752 | 10,800.934 | 9,155.959 | 7,489.784 | 5,836.471 | 4,985.408 | 4,970.06 |
| Brutowinstmarge
| 0.636 | 0.642 | 0.65 | 0.65 | 0.652 | 0.666 | 0.67 | 0.646 | 0.622 | 0.634 |
| Onderzoek- en ontwikkelingskosten
| 3,092.418 | 2,922.614 | 2,524.178 | 1,869.3 | 1,465.611 | 1,267.159 | 1,018.112 | 989.666 | 988.227 | 944.069 |
| Algemene en administratieve kosten
| 452.5 | 361.944 | 339.858 | 284.086 | 228.528 | 211.612 | 152.34 | 319.875 | 327.194 | 1,685.59 |
| Verkoop- en marketingkosten
| 5,702.924 | 4,801.555 | 3,998.948 | 3,611.687 | 3,605.667 | 3,202.234 | 2,726.864 | 2,400.934 | 2,175.827 | 2,085.355 |
| Verkoop-, algemene en administratieve kosten
| 7,065.352 | 5,163.499 | 4,338.806 | 3,895.773 | 3,834.196 | 3,413.845 | 2,879.204 | 2,720.808 | 2,503.021 | 3,770.946 |
| Overige kosten
| 420.289 | 726.579 | 472.974 | 354.467 | 363.215 | 99.131 | 51.782 | 302.613 | 128.106 | 248.538 |
| Bedrijfskosten
| 9,737.482 | 8,812.693 | 7,335.958 | 6,119.539 | 5,663.022 | 4,979.64 | 4,212.589 | 4,314.782 | 4,012.353 | 3,846.73 |
| Bedrijfsresultaat
| 12,261.468 | 10,990.515 | 9,065.717 | 7,455.16 | 5,378.792 | 4,278.156 | 2,879.586 | 1,548.943 | 961.396 | 1,207.531 |
| Bedrijfsresultaat ratio
| 0.355 | 0.362 | 0.359 | 0.355 | 0.325 | 0.311 | 0.258 | 0.172 | 0.12 | 0.154 |
| Totaal overige inkomsten en kosten netto
| 759.279 | -36.964 | -48.632 | -16.72 | -10.539 | 62.006 | -345.827 | 329.867 | 116.448 | 332.738 |
| Inkomen voor belasting
| 13,020.747 | 10,953.551 | 9,017.085 | 7,438.44 | 5,368.254 | 4,238.325 | 2,931.367 | 1,851.556 | 1,089.502 | 1,456.068 |
| Inkomen voor belasting ratio
| 0.377 | 0.361 | 0.357 | 0.354 | 0.324 | 0.308 | 0.262 | 0.205 | 0.136 | 0.186 |
| Belastingkosten
| 1,432.517 | 1,342.834 | 1,013.039 | 778.837 | 683.437 | 512.583 | 330.176 | 239.372 | 148.998 | 61.277 |
| Nettowinst
| 11,582.226 | 9,607.174 | 8,001.554 | 6,657.676 | 4,680.647 | 3,719.236 | 2,589.155 | 1,600.457 | 909.88 | 1,359.671 |
| Nettowinstmarge
| 0.335 | 0.316 | 0.317 | 0.317 | 0.283 | 0.27 | 0.232 | 0.177 | 0.114 | 0.174 |
| WPA (Winst Per Aandeel)
| 9.57 | 7.94 | 6.59 | 5.48 | 3.85 | 3.34 | 2.37 | 1.61 | 0.98 | 1.47 |
| Verwaterde WPA
| 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | 3.34 | 2.37 | 1.61 | 0.98 | 1.47 |
| EBITDA
| 13,300.641 | 11,972.416 | 9,838.103 | 8,154.336 | 5,929.446 | 4,692.523 | 3,449.521 | 2,313.047 | 1,803.849 | 1,170.103 |
| EBITDA ratio
| 0.385 | 0.394 | 0.389 | 0.388 | 0.358 | 0.341 | 0.309 | 0.256 | 0.225 | 0.149 |